Skip to main content
. 2021 Jul 19;8:697272. doi: 10.3389/fcvm.2021.697272

Table 2.

Serum levels of TMAO before and after 4-week and 8-week treatment with Taurisolo® in study participants stratified for gender.

Baseline t-4wk t-8wk
Mean ±SD Mean ±SD Δ% (vs. t0) p (vs. t0) Mean ±SD Δ% (vs. t0) p (vs. t0)
Men (n = 66) 2.57 ± 2.71 1.43 ± 1.41 −44.23 <0.0001 0.50 ± 0.38 −80.59 <0.0001
Women (n = 42) 2.11 ± 1.53 1.21 ± 0.94 −42.89 <0.0001 0.61 ± 0.67 −71.22 <0.0001

Statistical significance was calculated with Student's t-test; p < 0.05 was considered as significant.